Head-to-head · WeighScore
RxSpan MD vs Wellorithm
By GLP-1 ScorecardUpdated
Score comparison
RxSpan MD has the higher recorded score — 84.3/100 to 48.5/100.
RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | RxSpan MD | Wellorithm |
|---|---|---|
| WeighScore | 84.3/100 | 48.5/100 |
| Grade | B | C |
| Site position | #5 | #527 |
| Semaglutide | Current compounded quote unconfirmed | $147 first payment; $247 ongoing for compounded injection. Pricing says monthly; terms say every 28 days. Initial consultation and shipping included; usable supply unconfirmed. |
| Tirzepatide | Current compounded quote unconfirmed | $249 first payment; $349 ongoing for compounded injection. Pricing says monthly; terms say every 28 days. Initial consultation and shipping included; usable supply unconfirmed. |
| Coverage | Confirm treatment availability during intake | Advertises all 50 states plus D.C.; confirm the specific treatment, prescribing clinician and dispensing pharmacy for your location. |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Yes |
Site position #5 · B
Strengths
- Current public catalog lists Ozempic, Wegovy, Mounjaro and Zepbound
- Public terms describe independent healthcare providers
- Homepage describes messaging and care-team appointments
What to consider
- Homepage advertises compounded plans that the current catalog did not substantiate
- Current oral GLP-1 availability is unconfirmed
- Prior compounded prices are not a current quote; selected dose, supply, pharmacy and fee inclusions need confirmation
- Public terms do not establish unused prepaid-treatment refund amounts
Site position #527 · C
Strengths
- Publishes first and ongoing compounded injection charges separately
- Advertises the same medication price across its listed weekly dose ranges
- Initial consultation and shipping included in injection plan cards
- Lists four branded options and a generic oral dissolving-tablet option; exact quote and prescription still needed
What to consider
- Pricing says monthly renewal, while terms say billing every 28 days
- Oral ingredient, strength, supply and price not specified in the public injection table
- Branded pages carry inconsistent three-month/500mg footnotes; insurance service and cash-only terms need reconciliation
- Treating Professional Entities and dispensing pharmacy unnamed in the reviewed policies
- Consultation fee retention on clinical rejection is not quantified; processed-payment refunds are restricted
Featured provider
RxSpan MD
RxSpan MD scores 84.3/100 (B). RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.